These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11019397)

  • 1. Lymph and lymphangiogenesis: functional aspects.
    Shields JW
    Lymphology; 2000 Sep; 33(3):77-80. PubMed ID: 11019397
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular growth factors and lymphangiogenesis.
    Jussila L; Alitalo K
    Physiol Rev; 2002 Jul; 82(3):673-700. PubMed ID: 12087132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular control of lymphangiogenesis.
    Baldwin ME; Stacker SA; Achen MG
    Bioessays; 2002 Nov; 24(11):1030-40. PubMed ID: 12386934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The biology of lymphatic vessels - new findings ].
    Jussila L; Alitalo K; Kaipainen A
    Duodecim; 1998; 114(4):343-8. PubMed ID: 11466946
    [No Abstract]   [Full Text] [Related]  

  • 5. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T; Jussila L; Makinen T; Karpanen T; Jeltsch M; Petrova TV; Kubo H; Thurston G; McDonald DM; Achen MG; Stacker SA; Alitalo K
    EMBO J; 2001 Mar; 20(6):1223-31. PubMed ID: 11250889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Still more debate over VEGF.
    Isner JM
    Nat Med; 2001 Jun; 7(6):639-41. PubMed ID: 11385475
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of the avian lymphatic system.
    Wilting J; Papoutsi M; Othman-Hassan K; Rodriguez-Niedenführ M; Pröls F; Tomarev SI; Eichmann A
    Microsc Res Tech; 2001 Oct; 55(2):81-91. PubMed ID: 11596153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.
    Cooke SP; Boxer GM; Lawrence L; Pedley RB; Spencer DI; Begent RH; Chester KA
    Cancer Res; 2001 May; 61(9):3653-9. PubMed ID: 11325835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangiogenesis and tumor metastasis: more questions than answers.
    Pepper MS
    Lymphology; 2000 Dec; 33(4):144-7. PubMed ID: 11191654
    [No Abstract]   [Full Text] [Related]  

  • 11. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
    Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
    Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An avian model for studies of embryonic lymphangiogenesis.
    Wilting J; Schneider M; Papoutski M; Alitalo K; Christ B
    Lymphology; 2000 Sep; 33(3):81-94. PubMed ID: 11019398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo.
    Al-Khaldi A; Eliopoulos N; Martineau D; Lejeune L; Lachapelle K; Galipeau J
    Gene Ther; 2003 Apr; 10(8):621-9. PubMed ID: 12692590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
    Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
    Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.
    Qi JH; Claesson-Welsh L
    Exp Cell Res; 2001 Feb; 263(1):173-82. PubMed ID: 11161716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
    Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
    Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.
    Pepper MS; Rosnoblet C; Di Sanza C; Kruithof EK
    Thromb Haemost; 2001 Aug; 86(2):702-9. PubMed ID: 11522025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of vascular endothelial growth factor 165 drives peritumor interstitial convection and induces lymphatic drain: magnetic resonance imaging, confocal microscopy, and histological tracking of triple-labeled albumin.
    Dafni H; Israely T; Bhujwalla ZM; Benjamin LE; Neeman M
    Cancer Res; 2002 Nov; 62(22):6731-9. PubMed ID: 12438274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients.
    Young PP; Hofling AA; Sands MS
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11951-6. PubMed ID: 12195016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.